AAL

TWTR, DKS, EPZM Stocks On the Move Today

Epizyme shares are soaring after the company's cancer treatment was granted orphan drug status by the FDA

Jun 21, 2017 at 1:14 PM
facebook X logo linkedin


Stocks are mixed at midday, as traders weigh sliding oil prices against rallying tech shares. Among specific names making big moves are social media stock Twitter Inc (NYSE:TWTR), retailer Dick's Sporting Goods Inc (NYSE:DKS), and cancer treatment specialist Epizyme Inc (NASDAQ:EPZM). Here's a quick look at what's moving shares of TWTR, DKS, and EPZM.

TWTR Stock Pops on Positive Advertiser Feedback

Twitter shares are trading up 5.4% at $17.83, after Cleveland Research waxed optimistic on improvement in the company's strategy and execution, as well as the "constructive feedback" it's received from advertisers. TWTR stock is now boasting a 9.7% year-to-date lead, and is set to end atop both its 10- and 20-day moving averages for just the second time since mid-May. Nevertheless, the majority of analysts remain on the sidelines, with all but one of the 23 brokerages following Twitter maintaining a "hold" or worse rating.

DKS Stock the Latest Retailer on Amazon's Hit List

Dick's Sporting Goods shares have plunged 6% to trade at $37.19 -- fresh off a new annual low of $35.87 -- after Goldman Sachs said it expects Nike to begin selling its products on Amazon. DKS is now staring at a 30% year-to-date deficit, failing to capitalize on a recent burst of short covering. Since the May 1 reporting period, short interest on the stock has dropped 11.2%, while the security has lost more than one-quarter of its value over the same time frame.

EPZM Stock Jumps On Regulatory Nod for STS Cancer Drug

Epizyme stock was up 10.5% earlier, last seen trading 8% higher at $14.85. Boosting the shares is news the Food and Drug Administration's (FDA) granted orphan drug status to EPZM's soft tissue sarcoma (STS) treatment, tazemetostat. The security has surged nearly 60% since reporting positive mid-stage data for the drug last Wednesday, June 14 -- a move that may, in part, be due to a short squeeze. Almost 14% of EPZM's float is sold short, or eight days' worth of pent-up buying demand, at the stock's average pace of trading.

 

Two High-Octane Trade Ideas. One Simple Goal: Intraday Profits.

Dynamite Day Trading Signals delivers two same-day options trades every week — powered by proprietary intraday analysis and 43+ years of trading expertise.

But this isn’t just another stream of alerts.

It’s a structured plan with clear entry and exit points – designed for traders who want to act fast, trade smart, and wrap up gains before the closing bell.

No guesswork. No overnight exposure – Just two well-researched setups per week — whether you prefer buying premium or selling it.

And the results speak for themselves: subscribers have locked in +245.8% total profit over the last six months (since inception!).

👉 Start your one-month trial now for just $10, and be ready for the next trade alert.